InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-44.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Bruck Claudine, Director. Officer active across 2 companies, notably Navidea Biopharmaceuticals, INC.. In total, 7 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €9k. Activity tracked since 30 June 2021. The latest transaction was filed on 20 November 2023 (J). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
00Common StockSEC:0001104659-23-120749:0
1,000 shares@ US$6.0727.8% of flowCommon StockSEC:0001104659-23-120299:0
500 shares@ US$12.6128.9% of flowCommon StockSEC:0001104659-23-044208:0
181 shares@ US$27.660.0046% mcap50.0% of flowCommon StockSEC:0001415889-21-004864:0
Ideal exit: 8 Jul 2022 (T+270)
181 shares@ US$27.6621.7% of flowCommon StockSEC:0001415889-21-004864
Ideal exit: 8 Jul 2022 (T+270)
3,969 shares0Common StockSEC:0001437749-21-016596
3,969 shares0Common StockSEC:0001437749-21-016596:0
7 of 7 declarations
About Bruck Claudine
Claudine Bruck is a Director at NAVIDEA BIOPHARMACEUTICALS, INC. and Annovis Bio, Inc. She brings valuable expertise in the biopharmaceutical field, contributing to the strategy and governance of these companies. Her role as a director allows her to actively participate in strategic decision-making and oversee operations, thereby fostering growth and innovation.
